Loomis Sayles & CO L P Innoviva, Inc. Transaction History

Loomis Sayles & CO L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $12,091 - $13,798	-923 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $7,392 - $10,832	-540 Reduced 36.91%	923 $13,000
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $9,744 - $12,745	-698 Reduced 32.3%	1,463 $26,000
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $29,043 - $38,011	2,161 New	2,161 $30,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.